My Cart

Klotho beta

Klotho beta Overview

English NameKlotho betaApproved Drugs0
Drugs in Clinical Trials3Target SynonymKlotho Beta,Klotho Beta-Like Protein,B-Klotho,Klotho Beta Like,Beta-Klotho,EC 3.2.1,BKL,BetaKlotho,KLB
Highest Development StagePhase 2 Clinical
English NameKlotho beta
Target SynonymKlotho Beta,Klotho Beta-Like Protein,B-Klotho,Klotho Beta Like,Beta-Klotho,EC 3.2.1,BKL,BetaKlotho,KLB
Approved Drugs0
Drugs in Clinical Trials3
Highest Development StagePhase 2 Clinical

Klotho beta Background

KLB (Klotho Beta) is a Protein Coding gene. Among its related pathways are RET signaling and HIV Life Cycle. GO annotations related to this gene include hydrolase activity, hydrolyzing O-glycosyl compounds and fibroblast growth factor binding. An important paralog of this gene is KL. Klotho Beta is a regulator in multiple metabolic processes, while its role in cancer remains unclear. We found the expression of βKlotho was down-regulated in human hepatocellular carcinoma tissues compared with that in paired adjacent non-tumourous liver tissues. Hepatoma cells also showed decreased expression of βKlotho compared with normal hepatocyte cells. Reintroduction of βKlotho into hepatoma cells inhibited their proliferation.

Klotho beta Synonyms

betaKlotho,beta-klotho,BKL,KLB,klotho beta like,klotho beta-like protein

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
NGM-313NGM-313; MK-3655Phase 2 ClinicalNGM Biopharmaceuticals IncHepatitis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity
Details
JMT-202JMT202; JMT-202Phase 2 ClinicalShanghai Jmt-Bio IncHypertriglyceridemia
Details
DR-10624DR-10624; DR10624Phase 2 ClinicalZhejiang Doer Biologics CorpDiabetes Mellitus; Diabetes Mellitus, Type 2; Hypertriglyceridemia; Metabolic Dysfunction-Associated Steatotic Liver Disease; Metabolic Syndrome; Obesity; Overweight
Details
  • Overview
  • Product List
  • Clinical Drug Information